Diarrheal disease contributes substantially to illness and death in children in low-income countries ([@R1],[@R2]). Recent investigations of enteric illness have shown many cases with \>1 pathogen identified ([@R3]--[@R5]). The paradigm of 1 pathogen and 1 disease has been questioned with the advent of microbiological and molecular detection methods that have lower limits of detection. Children in developing countries are exposed to an array of pathogenic organisms. Recent studies have shown a complex relationship between gut microbiota and diarrheal illness; children with severe illness tend to have a less diverse microbiota and a predominance of specific genera of organisms ([@R6]). Molecular-based approaches to pathogen detection enhance the ability to quantify the abundance of pathogens shed in the stool.

Two recent studies of children in low-income countries have highlighted the need for pathogen quantitation. Lindsay et al., using the Global Enteric Multicenter Study (GEMS) specimen collection, found that 80% of controls and 89% of case-patients had detectable levels of *Shigella* spp. ([@R7]). To identify which children had shigellosis, Lindsay et al. determined a quantitative threshold and, when applied, it identified twice as many cases compared with standard culture. Platts-Mills et al., in a study of populations with a high prevalence of malnutrition and enteric infections in Tanzania, compared samples taken before and during diarrheal episodes ([@R8]). They did not find an association between the presence of any pathogen and diarrhea for 15 pathogens studied (rotavirus, adenovirus, astrovirus, norovirus, sapovirus, *Cryptosporidium* spp., *Giardia lamblia*, *Campylobacter jejuni*, *Clostridium difficile*, *Salmonella* spp., Shiga-toxigenic *Escherichia coli*, *Shigella* spp./enteroinvasive *E. coli* \[EIEC\], enterotoxigenic *E. coli* \[ETEC\], typical enteropathogenic *E. coli* \[tEPEC\], and enteroaggregative *E. coli* \[EAEC\]). However, when they considered quantity of pathogen on a continuous scale, 3 organisms (rotavirus, astrovirus, and *Shigella* spp.) were associated with diarrhea.

In disease-endemic settings, detection of multiple enteropathogens in asymptomatic and symptomatic children is common ([@R4],[@R9]). Samples from one third of patients with diarrhea in a hospital study in Kolkata, India, contained \>1 pathogen. Negative associations were demonstrated between *Shigella* spp. and rotavirus and *Shigella* spp. and *Vibrio cholerae* ([@R3]). However, a limitation of this study was that it was conducted only in patients with diarrhea. Thus, differential comparisons could not be made between pathogen associations in diarrheal and nondiarrheal samples. A recent study by Taniuchi et al. reported the etiology of diarrheal episodes by using molecular methods in Bangladeshi children during their first year of life. They found that multiple enteropathogens were present by the first month of life in stool specimens from healthy children and from children with diarrhea ([@R4]). If multiple pathogens are present, they might interact to increase or decrease the probability of symptomatic infection. Bhavnani et al. reported synergistic effects in rotavirus--*G. lamblia* and rotavirus--*E. coli* infections, in which the presence of these co-occurring organisms increased the probability of disease ([@R10]).

The gut microbiota are composed of thousands of species that might play a role in the risk for diarrhea. Some *Lactobacillus* and *Veillonella* species are potentially protective against diarrhea or serve as markers of healthy gut microbiota ([@R11]--[@R13]) Probiotic activity has been associated with some *Lactobacillus* spp., bifidobacteria, *Veillonella* spp., *Streptococcus* spp., *Enterococcus* spp., nonpathogenic *E. coli*, and *Saccharomyces boulardii* ([@R13]). Randomized clinical trials have investigated the role of some *Lactobacillus* spp. in treating infectious diarrhea and identified that these organisms can provide a benefit in the treatment of acute, infectious, watery diarrhea in infants and young children ([@R12]). In this study, we examined relationships between *Shigella* spp.*/*EIEC, microbiota, and diarrhea by using 16S rRNA marker gene surveys of stool specimens from a large international study of diarrhea in children \<5 years of age ([@R9]).

Methods
=======

Study Design and Participants
-----------------------------

We used stool specimens collected from children \<5 years of age who participated in a matched case--control study of moderate-to-severe diarrhea sponsored by the GEMS consortium ([@R14],[@R15]). In brief, the GEMS was a prospective case--control study of infants and young children at 7 sites in sub-Saharan Africa and southern Asia. Case-patients with moderate-to-severe diarrhea were enrolled when they came to a health clinic. Moderate-to-severe diarrhea eligibility criteria included dehydration (sunken eyes, loss of normal skin turgor, or a decision to initiate intravenous hydration), the presence of blood in the stool (dysentery), or a clinical decision to hospitalize the child. In the GEMS, matching controls (for sex, age, and community) were sampled from a demographic surveillance database of the area and included if they reported no diarrhea within the previous 7 days. For this study, 4 of the 7 GEMS sites (The Gambia, Mali, Kenya, and Bangladesh) elected to participate in further molecular characterization of their samples. When samples were sent for analysis, it was not required that their matched specimen be included, which resulted in disruption of matches. Including only samples with the complete matched set would have limited our sample size. Therefore, we included age and location as covariates in our analysis but did not analyze samples as matched sets.

All specimens for this study were collected during December 2007--December 2009. One specimen was collected for each child at the time of enrollment. The Institutional Review Boards at all participating institutions reviewed and approved the protocol.

Specimen Collection
-------------------

Stool specimens were handled according to the GEMS protocol ([@R16]). DNA was isolated from frozen stool specimens by using a bead beater with 3-mm diameter solid glass beads (Sigma-Aldrich, St. Louis, MO, USA) and, subsequently, with 0.1-mm zirconium beads (BioSpec Products, Inc., Bartlesville, OK, USA) to disrupt cells. The cell slurry was then centrifuged at 16,000 × *g* for 1 min, and the supernatant was processed by using QIAamp DNA Stool Extraction Kit (QIAGEN, Valencia, CA, USA). Extracted DNA was precipitated with ethanol and shipped to the United States.

Detection of EAEC, tEPEC, ETEC, Rotavirus, Norovirus, *G. lamblia*, and *Cryptosporidium* spp.
----------------------------------------------------------------------------------------------

Diagnostic microbiological methods for rotavirus, norovirus, *G. lamblia*, *Cryptosporidium* spp., and diarrheagenic *E. coli* (EAEC, tEPEC, and ETEC) were conducted at each site as described by Panchalingham et al. ([@R16]). In brief, *E. coli* isolates were selected from MacConkey agar plates and tested by using motility indole ornithine medium. EAEC, tEPEC, and ETEC pathotypes were identified by using PCRs for known virulence determinants of each pathogen (ETEC: heat-labile and heat-stable enterotoxins; tEPEC: intimin \[*eae*\] and bundle-forming pilus; and EAEC: *aatA* and *aaiC* genes).

Rotavirus was detected by using the ProSpecT ELISA Rotavirus Kit (Oxoid, Basingstoke, UK). Norovirus genogroups GI and GII were detected by using a multiplex PCR specific for synthesized complementary DNA after viral RNA extraction and reverse transcription. *G. lamblia* and *Cryptosporidium* spp. were detected by using commercially available immunoassays (TechLab, Blacksburg, VA, USA) following the manufacturer's protocols. Although the GEMS study tested for other enteric pathogens, our analysis included only pathogens that were present in ≥10 specimens. This lower limit was chosen after examination of the distribution of positive samples for each pathogen and to avoid statistical testing with small sample sizes.

Quantitative PCR for Detection of *ipaH* Gene in *Shigella* spp. and EIEC
-------------------------------------------------------------------------

Each stool DNA specimen was tested by using a quantitative PCR (qPCR) for *Shigella*/EIEC that included the 7500/700 Fast Real-Time PCR System, software V2·0·5, and SYBR green--based fluorescent dye (Applied Biosystems, Foster City, CA, USA). Details on primer design, PCR conditions, and standard curve analysis have been reported elsewhere ([@R4],[@R7],[@R17]). *Shigella*/EIEC was identified by using primers specific for the *ipaH* gene ([@R7]). We used a cutoff of 14,000 *ipaH* gene copies to distinguish children shedding low levels of *Shigella* spp. from those shedding high levels of *Shigella* spp. in their stools. The threshold was established by constructing receiver-operating characteristic curves to determine sensitivity and specificity of incremental increases in levels of *ipaH* compared with disease status and set on the basis of the point that maximized sensitivity and specificity ([@R7]). Stool specimens with high and low levels of *ipaH* indicate the relative amount of *Shigella* spp. detected.

16S rRNA Gene Sequencing and Analysis and Identification of *C. jejuni*
-----------------------------------------------------------------------

DNA was amplified by using universal primers specific for the V1--V3 region of the 16S rRNA gene in bacteria (518R \[5′-CAATTACCGCGGCTGCTGG-3′\] and 27F \[5′-AGAGTTTGATCCTGGCTCAG-3′\]). Individual reads were filtered for quality by using custom in-house scripts that removed low-quality sequences as described ([@R6]). Remaining high-quality sequences were separated into sample-specific sets according to barcodes. Conservative operational taxonomic units (OTUs) were clustered by using DNACLUST with parameters (--r 1 and 99% identity clusters) to ensure that the definition of an OTU was consistent across all samples ([@R18]). For taxonomic identification, a representative sequence from each OTU was aligned to the Ribosomal Database (RDP) (rdp.cme.msu.edu, release 10.4) by using BLASTn (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) with long word length (--W 100) to detect only nearly identical sequences ([@R19]). Sequences without a nearly identical match to the RDP (\>100-bp perfect match and \>97% identity, as defined by BLAST) were marked as being unassigned and assigned a unique OTU identifier. If a sample contained taxa classified as *C. jejuni,* we identified this sample as positive for *C. jejuni*.

Statistical Analysis
--------------------

Associations between high levels of *ipaH* and each additional pathogen, stratified by diarrheal status, were assessed for children with moderate or severe diarrhea and for controls by using separate logistic regression models with high levels of *ipaH* as the dependent variable. Logistic regression with moderate-to-severe diarrhea as the outcome of interest was then conducted to test for the interaction between high levels of *ipaH* and either 1) pathogenic microorganisms tested for by the GEMS or 2) species identified by 16S rRNA gene sequencing. All models were adjusted for potential confounding caused by location and age with categorical location and age terms in the model.

Statistical modeling was used to examine whether microbes interact to effect diarrhea risk. To assess whether the risk caused by having *Shigella* spp. and an additional microbe differed from the product of the risks caused by having each microbe separately (i.e., multiplicative interaction), we used a logistic regression model with an interaction term containing the level of *ipaH* and the additional microbe of interest ([Technical Appendix](#SD1){ref-type="local-data"} Figure). To assess whether the excess risk of having *ipaH* and an additional microbe differed from the sum of the excess risk of having each separately (i.e., additive interaction), we estimated the relative excess risk caused by the interaction (RERI, also called the interaction contrast ratio \[ICC\]) ([@R20]--[@R22]). An RERI = 0 indicates no additive interaction, an RERI\>0 suggests positive additive interaction, and an RERI\<0 suggests negative additive interaction. Ninety-five percent CIs were estimated by using the Hosmer-Lemeshow procedure ([@R23],[@R24]). All statistical analysis was performed by using SAS version 9·2 (SAS Institute, Cary, NC, USA) and R 2.15 ([@R25]), and p values \<0.05 were considered significant.

Results
=======

A total of 3,035 (1,735 nondiarrheal and 1,300 diarrheal) stool specimens from children \<5 years of age from The Gambia, Mali, Kenya, and Bangladesh were examined for *Shigella* spp. by identification of *ipaH* by qPCR; for *G. lamblia*, *Cryptosporidium* spp., and rotavirus by ELISA; for norovirus by PCR; for EAEC, ETEC, or tEPEC by culture and subsequent PCR; and for *C. jejuni* by 16S rRNA gene sequencing. Characteristics of samples are shown in [Table 1](#T1){ref-type="table"}. Diarrheal samples had a significantly higher number of pathogens (diarrheal mean 1.4, nondiarrheal mean = 0.95; p\<0.05).

###### Characteristics and pathogen abundance in children with cases of moderate-to-severe diarrhea and controls in low-income countries\*

  Characteristic                   Cases, n = 1,300   Controls, n = 1,735   p value    Total, n = 3,035
  -------------------------------- ------------------ --------------------- ---------- ------------------
  Male sex                         727 (56)           965 (56)              0.8677     1,692 (56)
  Age, mo, mean (SD)               16.7 (12)          17.8 (12)             0.0073     17.39 (12)
  0--5                             156 (12)           177 (10)              0.1167     333 (11)
  6--11                            413 (32)           465 (27)              0.0028     878 (29)
  12--23                           431 (33)           617 (35)              0.1674     1,048 (35)
  24--35                           185 (14)           311 (18)              0.0064     496 (16)
  36--59                           115 (9)            165 (10)              0.5318     280 (9)
  Country                          NA                 NA                    NA         NA
  The Gambia                       356 (27)           408 (23)              0.0151     764 (25)
  Mali                             103 (8)            114 (7)               0.1524     217 (7)
  Kenya                            636 (49)           779 (45)              0.0279     1,415 (47)
  Bangladesh                       205 (16)           434 (25)              \<0.0001   639 (21)
  *ipaH* gene copies ≥14,000       277 (22)           127 (7)               \<0.0001   404 (13)
  Rotavirus                        183 (14)           41 (2)                \<0.0001   224 (7)
  Norovirus genogroups GI or GII   127 (10)           141 (8)               0.1146     268 (9)
  *Giardia lamblia*                230 (18)           373 (22)              0.0093     603 (20)
  *Cryptosporidium*spp.            142 (11)           87 (5)                \<0.0001   229 (7)
  tEPEC                            106 (8)            104 (6)               0.0203     210 (7)
  EAEC                             253 (19)           347 (20)              0.7124     600 (20)
  ETEC                             181 (14)           148 (8)               \<0.0001   329 (11)
  *Camplylobacter jejuni*          341 (26)           264 (15)              \<0.0001   605 (20)
  Total pathogens, mean (SD)       1.4 (0.9)          0.9 (0.9)             \<0.0001   1.2 (0.9)

\*Values are no. (%) children unless otherwise indicated. NA, not applicable; tEPEC, typical enteropathogenic *Escherichia coli*; EAEC, enteroaggregative *E. coli*; ETEC, enterotoxigenic *E. coli*.

Associations and Interaction Effects of Co-occurring Pathogens
--------------------------------------------------------------

In 69% (278/404) of samples with high levels of *ipaH* (71% of diarrheal samples with high levels of *ipaH* and 64% nondiarrheal samples with high levels of *ipaH*), we identified an additional pathogen. In samples with low levels of *ipaH*, we identified an additional pathogen in 69% (1,815/2,631; 80% of diarrheal samples with low levels of *ipaH* and 62% of nondiarrheal samples with low levels of *ipaH*). After adjusting for age and location, rotavirus exhibited a negative association with high levels of *ipaH* in case-patients (odds ratio \[OR\] 0.31, 95% CI 0.17--0.55). In case-patients and controls, no other pathogen showed an association ([Figure 1](#F1){ref-type="fig"}; [Technical Appendix](#SD1){ref-type="local-data"} [Table 1](#T1){ref-type="table"}).

![Association of co-occurring pathogens with high levels of *ipaH* gene of *Shigella* spp. in stool specimens of children with diarrhea (cases) and children without diarrhea (controls) in low-income countries. Dark circles indicate means, and error bars indicate 95% CIs. tEPEC, typical enteropathogenic *Escherichia coli*; EAEC, enteroaggregative *E. coli*; ETEC, enterotoxigenic *E. coli*.](14-0795-F1){#F1}

Of the 8 pathogens tested, none showed any interaction effects. However, rotavirus was negatively associated with high levels of *ipaH* ([Table 2](#T2){ref-type="table"}), and only 15 samples that had high levels of *ipaH* were positive for rotavirus; 14 of these 15 samples were diarrheal samples. The presence of rotavirus and high levels of *ipaH* resulted in an OR of 29 (95% CI 3.8--220) for diarrheal risk. Although this point estimate was much higher than the expected additive effect of 11, this result and results of tests for interaction were not statistically significant ([Table 3](#T3){ref-type="table"}).

###### Interaction between level of *Shigella* spp.*/EIEC ipaH* gene and rotavirus and association with moderate-to-severe diarrhea in children in low-income countries\*

  Rotavirus status†                                               Low level of *ipaH* gene                        High level of *ipaH*gene   OR (95% CI) for *ipaH* gene within strata of rotavirus status                        
  --------------------------------------------------------------- -------------------------- -------------------- -------------------------- --------------------------------------------------------------- -------------------- ---------------------------
  Negative                                                        854/1,568                  1.00 (reference)                                263/126                                                         4.01 (3.18--5.05)    4.01 (3.18--5.05)
  Positive                                                        169/40                     7.56 (5.29--10.80)                              14/1                                                            28.85 (3.77--220)    3.82 (0.48--30.00)
  OR (95% CI) for rotavirus within strata of *ipaH* gene status   NA                         7.55 (5.29--10.80)                              NA                                                              7.20 (0.93--55.57)   Expected additive = 10.57

\*EIEC, enteroinvasive *Escherichia coli*; MSD, moderate-to-severe diarrhea; OR, odds ratio; NA, not applicable. †Model is unconditional and adjusted for age and location.

###### Measures of additive and multiplicative interactions of co-occurrence of *Shigella* spp. and another pathogen or *Lactobacillus* spp. in children in low-income countries\*

  Pathogen or organism             OR~10~† (95% CI)        OR~01~‡ (95% CI)        OR~11~§ (95% CI)        RERI (95% CI)               Additive p value   Multiplicative p value
  -------------------------------- ----------------------- ----------------------- ----------------------- --------------------------- ------------------ ------------------------
  *C. jejuni*                      3.84 (2.98--4.95)       1.97 (1.62--2.40)       5.55 (3.67--9.15)       0.79 (−2.15 to 3.73)        0.62               0.29
  ETEC                             3.77 (2.97--4.80)       1.69 (1.32--2.18)       4.65 (2.32--9.30)       0.15 (−3.20 to 3.52)        0.92               0.41
  tEPEC                            3.69 (2.91--4.69)       1.36 (1.02--1.83)       4.09 (2.01--8.33)       0.03 (−2.99 to 3.06)        0.99               0.61
  *Cryptosporidium* spp.           3.79 (2.99--4.81)       2.40 (1.78--3.24)       4.95 (2.28--10.75)      −0.27 (−4.27 to 3.73)       0.91               0.16
  Rotavirus                        4.01 (3.18--5.05)       7.56 (5.29--10.80)      28.85 (3.77--220)       18.29 (−40.32 to 76.91)     0.54               0.96
  Norovirus genogroups GI or GII   3.65 (2.87--4.64)       1.14 (0.86--1.51)       4.00 (2.08--7.71)       0.21 (−2.56 to.98)          0.88               0.91
  EAEC                             3.59 (2.78--4.63)       0.87 (0.71--1.07)       3.29 (2.06--5.26)       −0.17 (−1.92 to 1.58)       0.85               0.86
  *Giardia lamblia*                3.65 (2.84--4.69)       0.83 (0.68--1.02)       2.70 (1.63--4.49)       −0.78 (−2.83 to 0.83)       0.35               0.70
  *Lactobacillus* taxon                                                                                                                                   
  KLDS 1.0718                      **4.10 (3.19--5.26)**   **1.25 (1.01--1.55)**   **2.42 (1.41--4.13)**   **−1.93 (−3.56 to 0.29)**   **0.02**           **0.02**
  *L. salivarius*                  4.12 (3.20--5.31)       1.77 (1.45--2.16)       3.88 (2.35--6.38)       −1.02 (−3.18 to 1.14)       0.36               **0.03**
  *L. ruminis*                     **4.30 (3.19--5.79)**   **0.82 (0.69--0.96)**   **2.20 (1.55--3.13)**   **−1.92 (−3.36 to 0.47)**   **0.01**           **0.05**
  DJF RP24                         **4.59 (3.41--6.16)**   **0.85 (0.72--0.99)**   **1.99 (1.39--2.85)**   **−2.44 (−3.93 to 0.95)**   **0.001**          **0.01**
  TSK G32--2                       **3.89 (3.08--4.92)**   **1.40 (1.07--1.85)**   **1.60 (0.59--4.30)**   **−2.69 (−4.55 to 0.84)**   **0.004**          **0.02**

\*OR, odds ratio; RERI, relative excess risk caused by the interaction; ETEC, enterotoxigenic *Escherichia coli*; tEPEC, typical enteropathogenic *E. coli*; EAEC, enteroaggregative *E. coli*. Boldface indicates significance (p≤0.05). Under an additive interaction, OR~11~ -- OR~10~ -- OR~01~ + 1 = 0. Under a multiplicative interaction, OR~11~ = OR~10~OR~01~. †OR caused by having a high level of the *ipaH* gene alone (in the absence of the other pathogen or *Lactobacillus* taxon). ‡OR caused by having the other pathogen or *Lactobacillus* taxon alone (in the absence of a high level of the *ipaH*gene). §OR caused by having a high level of the *ipaH* gene and another pathogen or *Lactobacillus* taxon (relative to having neither).

Interaction Effects of *Lactobacillus* and *Veillonella* Taxa
-------------------------------------------------------------

A total of 61 *Lactobacillus* and *Veillonella* taxa were identified by 16S rRNA gene sequencing. Analyses were limited to 31 taxa that co-occurred in samples with high levels of *ipaH* ≥10 times. We tested for interaction between high levels of *ipaH* and the identified 16S rRNA gene taxon by using a logistic regression model adjusted for age and location, including an interaction term between level of *ipaH* and taxon presence ([Technical Appendix](#SD1){ref-type="local-data"} Table 2). Five taxa showed significant negative multiplicative interactions identified by an interaction term with p ≤ 0·05. Of these taxa, *Lactobacillus ruminis* (RERI −1.92, 95% CI −3.36 to 0.47), *Lactobacillus* DJF-RP24 (RERI −2.44, \[95% CI −3.93 to 0.95), *Lactobacillus* KLDS 1.0718 (RERI −1.93, 95% CI −3.56 to 0.29), and *Lactobacillus* TSK G32.2 (RERI −2.69, 95% CI −4.55 to 0.84\]) showed additive interactions ([Table 3](#T3){ref-type="table"}). The combined effect of high levels of *ipaH* in the presence of *L. ruminis, Lactobacillus* DJF RP24, *Lactobacillus* KLDS 1.0718, or *Lactobacillus* TSK G32.2 was lower than expected ([Figure 2](#F2){ref-type="fig"}; [Technical Appendix](#SD1){ref-type="local-data"} Table 3), which suggested an antagonistic interaction or a decreased association with diarrhea when specific *Lactobacillus* taxa were present than versus when they were absent. When we tested the 4 *Lactobacillus* taxa against 8 additional pathogens; no additive interaction was observed ([Technical Appendix](#SD1){ref-type="local-data"} Table 4).

![Departure from additivity between level of *ipaH* gene and presence of *Lactobacillus* taxon TSK G32-2 on odds of moderate-to-severe diarrhea in children in low-income countries. The reference group is TSK G32-2 negative, low level of *ipaH*. The observed combined joint effect of a high level of the *ipaH* gene and TSK G32-2 was lower than the expected additive effect. Gray bars indicate effect of TSK G32-2; black bars indicate effect of high levels of *ipaH*; and white bar indicates observed joint effect of TSK G32-2 and high levels of *ipaH*. Neg, negative; Pos, positive; Exp, expected; Obs, observed.](14-0795-F2){#F2}

16S rRNA Gene--based Bacterial Community Profiles
-------------------------------------------------

The proportional abundance of the 9 most common genera identified by 16S rRNA marker gene sequencing differed among stool specimens with high and low levels of *ipaH* and among specimens from children with and without diarrhea ([Figure 3](#F3){ref-type="fig"}). Overall composition of diarrheal stool specimens had an increased relative proportional abundance of facultative anaerobes when compared with composition of nondiarrheal stool specimens, even when diarrheal stool specimens had low levels of *ipaH* (mean diarrheal specimens 0.47, mean nondiarrheal specimens 0.22; p\<0.0001). Overall, diarrheal stool specimens with high levels of *ipaH* had the lowest proportion abundance of *Prevotella* spp. (0.11), diarrheal stool samples with low levels of *ipaH* had the second lowest proportional abundance (0.15), and nondiarrheal stool specimens with high and low levels of *ipaH* had similar proportion abundances for *Prevotella* spp. (0.25 and 0.24, respectively; p = 0.63).

![Overall 16S rRNA gene--based bacterial community profiles (proportional abundance) of diarrheal samples with high levels of *ipaH* gene (n = 277), diarrheal samples with low levels of *ipaH* gene (n = 1,023), nondiarrheal samples with high levels of *ipaH* gene (n = 127), and nondiarrheal samples with low levels of *ipaH* gene (n = 1,608) from children in low-income countries. Other indicates sequences that were not identified as 1 of the 9 most abundant taxa or did not have good (\>100 bp exact match, \>97% identity) matches with isolate sequences from the Ribosomal Database Project ([@R19]).](14-0795-F3){#F3}

*Shigella* spp. identified by the *ipaH* qPCR were a subset of the genera *Escherichia/Shigella* identified by 16S rRNA gene sequencing, but could not be distinguished from commensal strains. Diarrheal specimens had a larger proportion of members of the genera *Escherichia/Shigella* (p\<0.0001) than nondiarrheal specimens, regardless of levels of *ipaH*. However, diarrheal stool specimens with high levels of *ipaH* had a significantly higher proportion of *Escherichia/Shigella* sequences (31%; p\<0.0001) than did diarrheal stool specimens with low levels of *ipaH*.

Members of the genus *Veillonella* was found equally in diarrheal and nondiarrheal stool specimens. Streptococci were found more often in diarrheal stool specimens, regardless of levels of *ipaH*. There was no association between Shannon diversity indices and levels of *ipaH* (p = 0.95), although diversity was significantly associated with age, location, and moderate-to-severe diarrhea (p\<0.0001, p = 0.004, and p\<0.0001, respectively) ([Figure 4](#F4){ref-type="fig"}).

![Shannon diversity index for diarrheal and nondiarrheal samples with high (A) and low (B) levels of *Shigella* spp. *ipaH* gene stratified by age group for children in low-income countries. Box and whisker plot indicates distribution of diversity index for each group. The upper whisker extends from the 75th percentile to the highest value that is ≤1.5× the interquartile range (IQR) of the hinge (upper end) or the distance between the first and third quartiles. The lower whisker extends from the hinge (lower end) to the lowest values 1.5× the IQR of the hinge. Diamonds indicate means and horizontal lines indicate medians. Points outside the ends of the whiskers are outliers beyond 1.5× the IQR of the hinge.](14-0795-F4){#F4}

Discussion
==========

In this study, we used qPCR and 16S rRNA gene sequencing to identify interactions between *Shigella*/EIEC and co-occurring enteric pathogens or microbes within the gut microbiota in children with moderate-to-severe diarrhea. We explored these interactions in stool specimens obtained from children with and without diarrhea who participated in the international GEMS study. We used detection of the *ipaH* gene as an indicator of *Shigella*/EIEC infection because this molecular method is highly sensitive and specific ([@R4],[@R26],[@R27]). Use of quantitative identification methods, rather than colonization ([@R7],[@R8]), is advantageous for identifying true disease associations. We found that 69% (1,815/2,631) of stool samples with high levels of *ipaH* had a co-occurring pathogen.

This study confirms the findings of the negative association between rotavirus and *Shigella* spp. in polymicrobial infections in diarrheal patients in India and The Gambia (*Shigella* spp./rotavirus: OR 0.36, 95% CI 0.14--0.92) ([@R3],[@R28]). Although we identified correlations between rotavirus and *Shigella* spp. as determined by levels of *ipaH*, no pathogen showed an antagonistic or synergistic interaction on the odds of moderate-to-severe diarrheal illness. Although all but 1 of the rotavirus-positive samples that had high levels of *ipaH* were associated with diarrhea cases, the negative association between these pathogens gave us limited sample size to assess a possible synergistic effect. A synergistic effect between high levels of *ipaH* and rotavirus (RERI/ICC 9.9, 95% CI 2.6--28.4) was previously observed in Ecuador, and it was concluded that pathogenic potential appears to be enhanced during co-infection ([@R10]). Our RERI/ICC was 18, but the effect was not significant, possibly because of small sample size.

The GEMS was designed as a matched case--control study of thousands of stool samples from persons matched by age, sex, community, and time. A possible limitation of our methods is that we did not use matched pairs but rather adjusted for country-level location and age by using statistical modeling. This method was used because of the large number of broken matched pairs. Thus, inclusion of all samples greatly increased our sample size. Generally, the lack of an appropriate matched analysis biases the effect on estimates toward the null. However, studies have shown that including samples with missing data and adjusting by using confounding terms is valuable, particularly with a larger sample size ([@R29],[@R30]). We adjusted for location at the country level, and the GEMS matched case-patients at the community level, which could fail to adequately address bias, particularly when one considers that the distribution of case-patients and controls differed at multiple sites and that *Shigella* spp. are more common in Bangladesh. An additional limitation of our study design is that, given a cross-sectional study sample set, we were unable to identify temporal associations and to attribute cause and effect. Furthermore, associations between pathogens and taxa may be explained by seasonality, and further work should be conducted to investigate this as a possible explanation. Finally, the 16S rRNA gene-sequencing method used to identify taxa of interest is limited because our identification was only as precise as the RDP attributed taxonomy. Thus, further characterization and species-specific identification are warranted in uncultured bacteria such as *Lactobacillus* KLDS 1.0718.

A previous study showed cross-sectional differences in stool microbiota of children with diarrhea compared with children without diarrhea in low-income countries ([@R6]). Our study showed that the composition of microbiota is more closely associated with diarrheal status than with co-infection by *Shigella* spp./EIEC as measured by high levels of *ipaH*. Microbiota in stools of children without diarrhea but who had high levels of *ipaH* (i.e., were colonized with *Shigella* spp./EIEC) were more similar to microbiota of healthy children with low levels of *ipaH* than microbiota in samples from children with diarrhea and high levels of *ipaH*.

In low-income countries, infection/colonization with pathogens occurs commonly in persons without diarrhea. Our study found little evidence of interaction between *Shigella* spp. and co-occurring pathogens. Although the cross-sectional study design precludes strong statements of cause and effect, our data are consistent with the possibility that some *Lactobacillus* taxa naturally occurring in the gut and are protective against *Shigella* spp.--induced diarrhea. Future studies should continue to consider the effects of co-occurring species.

###### 

**Technical Appendix.** Supplementary information regarding microbiota tested for their effects on risk for shigellosis in children in low-income countries.
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